Search results
Beximco Pharmaceuticals Ltd. (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets ...
- About
Beximco Pharmaceuticals Limited is a leading manufacturer...
- Products
Products - Beximco Pharmaceuticals Ltd.
- Investors
Investors - Beximco Pharmaceuticals Ltd.
- Health
Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer...
- Newsroom
Newsroom - Beximco Pharmaceuticals Ltd.
- Contact
Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer...
- Company Information
Company Information - Beximco Pharmaceuticals Ltd.
- Financial Reports
Financial Reports - Beximco Pharmaceuticals Ltd.
- About
Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. [ 5 ] Today, Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and ...
Find company research, competitor information, contact details & financial data for BEXIMCO PHARMACEUTICALS USA INC of Suwanee, GA. Get the latest business insights from Dun & Bradstreet.
- 4110 Regal Oaks Dr, Suwanee, 30024-7453
- Chairperson
- Local vs International Manufacturing
- Technology Transfer
- 1976 to The Present
- Environmental Concerns
Beximco's main manufacturing site is spread across a 22-acre area located near Dhaka, Bangladesh’s capital city. To build a better picture of the local manufacturing landscape Beximco works with, Reza explains that though companies in Bangladesh are producing large quantities of molecules, the actual number of products coming out of the country is ...
BEXIMCO BY THE NUMBERS: –15 million canisters of metered-dose inhalers per annum –36 million units of dry powder inhaler per annum –37 million units of liquid dosage per annum –6 million units of creams and ointments per annum –10 million units of suppositories per annum –5 billion tablets on a single shift It is interesting to consider the lack of...
Incorporated more than 40 years ago in 1976, the journey the company has taken is important to understanding how it got to where it is today. The pharmaceutical company operates within a larger organisation, but a Group is not a legal entity in Bangladesh. This means that the many branches of Beximco have little to do with one another, and mostly j...
One of the biggest future concerns for pharmaceutical companies across emerging and developed markets is sustainability; both financial and environmental. Commenting on Beximco's eco-friendly initiative, Reza says that the UN actually shows Beximco as an example in third world countries for how it cares for the environment. He talks about the compa...
Beximco Pharma commences export to the United States. --August 5, 2016. Beximco Pharmaceuticals Limited (“BPL”, “Beximco Pharma” or “Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces it has commenced the export of Carvedilol, a ...
Beximco Pharmaceuticals Ltd (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets around ...
People also ask
Where is Beximco Pharma made?
When was Beximco founded?
Who is Beximco Pharmaceuticals Ltd (BPL)?
Is Beximco a US drug company?
Mar 25, 2021 · The Bangladeshi company was founded in 1976. Four years later, Beximco Pharmaceuticals started manufacturing products under the licences of Germany-based Bayer and Upjohn of the US, and launched its own formulation brands three years later. In 1985, it was listed on the Dhaka Stock Exchange. Today, Beximco manufactures and markets its own ...
